JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Latest Updates

This page lists all changes to DSG-WB 203 after Release 01.

Changes Introduced with Release 70

Hepatitis A and Parvovirus B19 - Change Notification No. 06 - 2024
Transgender and Non-Binary Donors - Change Notification No. 09 - 2024

Changes Introduced with Release 69

Air Crew and Air Traffic Controllers - Change Notification No. 27 - 2023
Blood Safety Entry - Change Notification No. 28 - 2023
Chronic Fatigue Syndrome - Change Notification No. 29 - 2023

Changes Introduced with Release 68

Frequency of Donation - Change Notification No. 10 - 2023
Recurrent Thrombophlebitis - Change Notification No. 11 - 2023
Tropical Viruses - Change Notification No. 12 - 2023
Hepatitis B and Hepatitis of Unknown Cause - Change Notification No. 18 - 2023

Changes Introduced with Release 67

Mpox (Monkeypox) - Change Notification No. 04 - 2023
Donor Weight - Change Notification No. 03 - 2023
Dental Treatment - Change Notification No. 02 - 2023

Changes Introduced with Release 66

Platelet Count - Change Notification No. 59 - 2022
Liver Disease - Change Notification No. 58 - 2022
Thrombosis and Thrombophilia - Change Notification No. 57 - 2022
Air Crew & Air Traffic Controllers - Change Notification No. 56 - 2022

Changes Introduced with Release 65

Table of Immunisations - Change Notification No. 49 - 2022
Hepatitis of Unknown Cause - Change Notification No. 48 - 2022
Coronavirus Infection - Change Notification No. 46 - 2022
Surgery - Change Notification No. 45 - 2022
Sleep Apnoea - Change Notification No. 44 - 2022
Addiction and Drug Abuse - Change Notification No. 43 - 2022

Changes Introduced with Release 64

Hepatitis B - Change Notification No. 39 - 2022
Monkeypox - Change Notification No. 40 - 2022

Changes Introduced with Release 63

Body Piercing - Change Notification No. 28 - 2022
Conn’s Syndrome - Change Notification No. 27 - 2022
Ehlers Danlos Syndrome - Change Notification No. 26 - 2022
Narcolepsy - Change Notification No. 25 - 2022
Appendix 4 - Management of post donation illness - Change Notification No. 22 - 2022
Tropical Viruses - Change Notification No. 21 - 2022
Inflammatory Bowel Disease  - Change Notification No. 20 - 2022
Indwelling Shunts and Stents  - Change Notification No. 19 - 2022

Changes Introduced with Release 62

Coronavirus Infection - Change Notification No. 29 - 2022

Changes Introduced with Release 61

Trying to Conceive - Change Notification No. 08 - 2022
Non-Contagious Diseases - Change Notification No. 07 - 2022
Malignancy - Change Notification No. 06 - 2022
Kidney & Bladder Disease - Change Notification No. 05 - 2022
Complementary Therapy - Change Notification No. 04 - 2022
Alopecia - Change Notification No. 03 - 2022
Allergy - Change Notification No. 02 - 2022

Changes Introduced with Release 60

Coronavirus Infection - Change Notification No. 01 - 2022

Changes Introduced with Release 59

Blood Safety Entry - Change Notification No. 45 - 2021

Changes Introduced with Release 58

Plasma Changes - Change Notification No. 15 - 2021

Changes Introduced with Release 57

The FAIR Study - Change Notification No. 16 - 2021

Changes Introduced with Release 56

Coronavirus Infection - Change Notification No. 06 - 2021
Diabetes Mellitus - Change Notification No.07 - 2021
Hypercholesterolaemia - Change Notification No. 08 - 2021

Changes Introduced with Release 55

Coronavirus Infection - Change Notification No. 04 - 2021
Acitretin in Acne Psoriasis and Skin Disease - Change Notification No. 72 - 2020
Body Piercing - Change Notification No. 71 - 2020
Drug Index  - Change Notification No. 70 - 2020
Animal Bites and Rabies - Change Notification No. 69 - 2020
South American Trypanosomiasis - Change Notification No. 58 - 2020
Viral Haemorrhagic Fever  - Change Notification No. 57 - 2020
Sodium Valproate - Change Notification No. 56 - 2020
Tropical Virus - Change Notification No. 55 - 2020
Latent Tuberculosis - Change Notification No. 54 - 2020
Haemochromatosis - Change Notification No. 53 - 2020
Cervical Carcinoma In Situ - Change Notification No. 52 - 2020
Clopidogrel - Change Notification No. 51 - 202

Changes Introduced with Release 54

COVID-19 Vaccine - Change Notification No. 73 - 2020

Changes Introduced with Release 53

Clinical Trials - Change Notification No. 65 - 2020
Coronavirus Infection - Change Notification No. 64 - 2020

Changes Introduced with Release 52

Transfusion - Change Notification No. 48 - 2020

Changes Introduced with Release 51

Coronavirus Infection - Change Notification No. 29 - 2020

Changes Introduced with Release 50

Nothern Ireland - donor selection changes 2020 - Change Notification No. 28 - 2020

Changes Introduced with Release 49

Haemoglobin Estimation - Change Notification No. 26 - 2020

Changes Introduced with Release 48

Coronavirus Infection - Change Notification No. 13 - 2020

Changes Introduced with Release 47

Coronavirus Infection - Change Notification No. 09 - 2020

Changes Introduced with Release 46

Coronavirus Infection - Change Notification No. 08 - 2020

Changes introduced with Release 45

Coronavirus Infection - Change Notification No. 03 - 2020

Changes introduced with Release 44

Familial Pseudohyperkalaemia - Change Notification No. 26 - 2019
Palpitations & Arrhythmias - Change Notification No. 27- 2019

Changes introduced with Release 43

HCV Northern Ireland - Change Notification No. 11 - 2019
HTLV - Change Notification No. 10 - 2019
Cervical Carcinoma in Situ - Change Notification No. 09 - 2019
Blood Safety Entry England, Wales, Scotland - Change Notification No. 08 - 2019
Blood Safety Entry Northern Ireland - Change Notification No. 07 - 2019
Pre- and Post-Exposure Prophylaxis for HIV prevention - Change Notification No. 04 - 2019
Pregancy - Change Notification No. 03 - 2019
Malignancy - Change Notification No. 02 - 2019
Hepatitis C - Change Notification No. 01 - 2019

Changes introduced with Release 42

Hepatitis A - Change Notification No. 20 - 2018
Narcolepsy - Change Notification No. 21 - 2018

Changes introduced with Release 41

Hepatitis E - See Change Notification No.17 - 2018

Changes introduced with Release 40

Surgery - Change Notification No. 52 - 2017
Endoscopy - Change Notification No. 51 - 2017
Bleeding Disorder - Change Notification No. 49 - 2017
Syphilis - Change Notification No. 47 - 2017
Sex Worker - Change Notification No. 45 - 2017
Non -Consented Exposure to Human Body Fluids - Change Notification No. 44 - 2017
HTLV - Change Notification No. 41 - 2017
Homosexual and Bisexual Individuals - Change Notification No. 39 - 2017
HIV - Change Notification No. 37 - 2017
Hepatitis C - Change Notification No. 35 - 2017
Hepatitis B - Change Notification No. 33 - 2017
Complementary Therapy - Change Notification No. 31 - 2017
Body Piercing - Change Notification No. 29 - 2017
Blood Safety Entry - Change Notification No. 26 - 2017

Changes introduced with Release 39

Drug Index - Change Notification 19 - 2017
Thyroid - Change Notification No. 18 - 2017

Changes introduced with Release 38

Malaria - Change Notification No. 15 - 2017
Tissue and Organ Recipients - Change Notification No. 14 - 2017
Radiation Therapy - Change Notification No. 13 - 2017
Eye Disease - Change Notification No. 12 - 2017
Autoimmune - Change Notification No. 11 - 2017
Osteopenia - Change Notification No. 11 - 2017

Changes introduced with Release 37

Hepatitis A - Change Notification No. 04 - 2017
Central Nervous System Disease - Change Nofication No.03 - 2017

Changes introduced with Release 36

Cardiac surgery clarification - Change Notifcation No. 37 -2016

Changes introduced with Release 35

Blood Safety Entry and  Homosexual and Bisexual Individuals - Change Nofication No. 36 - 2016

Changes introduced with Release 34

Tropical Viruses - Change Notification No. 35 - 2016

Changes introduced with Release 33

Acne - Change Notification No. 18 - 2016
Disabled Donor - Change Notification No. 19 - 2016
High Haemoglobin - Change Notification No. 20 - 2016
Immunoglobulin - Change Notification No. 21 - 2016

Changes introduced with Release 32

Tropical Viruses - Change Notification No. 014 - 2016
Viral Haemorrhagic Fever - Change Notification No. 015 - 2016

Changes introduced with Release 31

Viral Haemorrhagic Fever - Change Notification No. 11 -2016
West Nile Virus - Change Notification No. 09 - 2016
Tropical Viruses - Change Notification No. 08 - 2016
Kidney and Bladder Disease Disease - Change Notification No. 06 - 2016
Memorial Tattoos, Body Piercing - Change Notification No. 05 - 2016
Appendix 2 Table of Immunizations - Change Notification No. 04- 2016
Hepatitis E - Change Notification No. 03 - 2016
Hepatitis A - Change Notification No. 02 - 2016
Glycogen Storage Disease - Change Notification No. 01 - 2016

Changes introduced with Release 30 

Alopecia and Automimmune Disease - Change Notification No 25 - 2015
Chronic Fatigue Syndrome - Change Notification No 26 - 2015

Changes introduced with Release 29

Central Nervous System - Change Notification No 10 - 2015
Communication Difficulties - Change Notification No 11 - 2015
Complementary Therapy - Change Notification No 12 - 2015
Injectable Tanning Agents - Change Notification No 15 - 2015

The changes made with CN No. 15 - 2015 to the Blood Safety Entry have also been made to the Blood and Tissue Safety Entry N.I. Injectable Tanning Agents has been added to index and linked to Blood Safety Entry (England, Scotland and Wales).

Changes introduced with Release 28

Asthma - Change Notification No 02 - 2015
Kidney and Bladder Disease - Change Notification No 03 - 2015
Malignancy - Change Notification No 04 - 2015
Nonsteroidal Anti-Inflammatory Drugs and Drug Index - Change Notification No 05 - 2015

Changes introduced with Release 27

Hepatitis of Unknown Cause - Change Notification No 44 - 2014
Tuberculosis - Change Notification No 45 - 2014
Mental Health Problems - Change Notification No 46 - 2014
Respiratory Disease - Change Notification No 47 - 2014
Thrombosis - Change Notification No 48 - 2014

Changes introduced with Release 26

Viral Haemorrhagic Fever Risk - Change Notification No. 43 - 2014

Changes introduced with Release 25

West Nile Virus - Change Notification No. 42 - 2014

Changes introduced with Release 24

Chikungunya Virus Risk - Change Notification No. 41 - 2014

Changes introduced with Release 23

Chikungunya Virus Risk - Change Notification No. 27 - 2014

Changes introduced with Release 22

Accept - Change Notification No. 18 - 2014
Autoimmune Disease - Change Notification No. 19 - 2014
Central Nervous System Disease - Change Notification No. 20 - 2014
Complementary Therapy - Change Notification No. 21 - 2014
Kidney and Bladder Disease - Change Notification No. 22 - 2014
Osteopenia - Change Notification No. 23 - 2014
Vitamins and Other Nutritional Supplements - Change Notification No. 24 - 2014
Chikungunya Virus - Change Notification No. 26 - 2014

Changes introduced with Release 21

Chikungunya Virus - Change Notification No. 01 - 2014

Changes introduced with Release 20

Malignancy - Change Notification No. 18 - 2013
Skin Disease and Dermatitis - Alitretinoin - Change Notification No. 20 - 2013
South American Trypanosomiasis - Change Notification No. 21 - 2013
Surgery - Change Notification No. 22 - 2013

Changes introduced with Release 19

West Nile Virus (WNV) - Change Notification No. 14 - 2013

Changes introduced with Release 18

Hepatitis B - Change Notification No. 02 - 2013
Infection Chronic -Change Notification No. 03 - 2013
Chest Pain - Change Notification No. 05 - 2013
Cardiovascular Disease - Change Notification No. 06 - 2013
Wounds, Mouth and Skin Ulcers - Change Notification No. 07 - 2013

Changes introduced with Release 17

West Nile Virus (WNV) - Change Notification No. 01 - 2013

Changes introduced with Release 16

Sickle-Cell Trait - Change Notification No. 27 - 2012
Kidney Disease - Change Notification No. 28 - 2012
Decompression Illness - Change Notification No. 29 - 2012

Changes introduced with Release 15

West Nile Virus (WNV) - Change Notification No. 25 - 2012
West Nile Virus (WNV) - Change Notification No. 26 - 2012

Changes introduced with Release 14

Malaria - Change Notification No. 20 - 2012
West Nile Virus - Change Notification No. 21 - 2012
Cupping/Wet Cupping - Change Notification No. 22 - 2012
Cardiovascular Disease - Change Notification No. 23 - 2012
Mobilised Granulocytes - Change Notification No. 24 - 2012

Changes introduced with Release 13

West Nile Virus (WNV) - Change Notification No. 19 - 2012

Changes introduced with Release 12

Acne - Change Notification No. 06 - 2012
Toxoplasmosis - Change Notification No. 07 - 2012
Psoriasis - Change Notification No. 08 - 2012
Pregnancy - Change Notification No. 09 - 2012
Dermatitis - Change Notification No. 10 - 2012
Skin Disease - Change Notification No. 11 - 2012
Cardiovascular Disease - Change Notification No. 12 - 2012
Cardiac Surgery - Change Notification No. 13 - 2012

Changes introduced with Release 11

West Nile Virus (WNV) - Change Notification No. 03 - 2012

Changes introduced with Release 10

Donor Weight - Change Notification No. 22 - 2011
Cardiovascular Disease - Change Notification No. 23 - 2011
Surgery - Change Notification No. 24 - 2011
XMRV - Change Notification No. 25 - 2011
Hepatitis C - Change Notification No. 26 - 2011

Changes introduced with Release 09

Blood Safety Entry - Change Notification No. 16 - 2011
Homosexual and Bisexual Individuals - Change Notification No. 17 - 2011
West Nile Virus (WNV) - Change Notification No. 19 - 2011

Changes introduced with Release 08

West Nile Virus (WNV) - Change Notification No. 18 - 2011

Changes introduced with Release 07

West Nile Virus (WNV) - Change Notification No. 15 - 2011

Changes introduced with Release 06

West Nile Virus (WNV) - Change Notification No. 11 - 2011

Changes introduced with Release 05

Pregnancy - Change Notification No. 01 - 2011
Trying to Conceive - Change Notification No. 02 - 2011
Immunization - Live - Change Notification No. 03 - 2011
Syphilis - Change Notification No. 04 - 2011
Porphyria - Change Notification No. 05 - 2011

Changes introduced with Release 04

Donor Weight and Donation Volumes - Change Notification No. 13 - 2010

Changes introduced with Release 03

Chronic Fatigue Syndrome - Change Notification No. 08 - 2010

Changes introduced with Release 02

West Nile Virus (WNV) - Change Notification No. 09 - 2010